We believe it will not only help address the growing diabetes burden in the country but also serve as a key driver of sustainable, long-term value creation for Eris.Established in 2007, Eris is the youngest among the Top 20 pharma companies in India
10.1038/s41586-024-07516-8 11 CamilleC.Goff OcaneL.FrdricS.VasseurF.TanouM.NguyenC.et al (2021)
Be wary of knockoff or non-prescription versions of these medications that have not been thoroughly tested for safety or efficacy
The percentage varies based on protein intake, exercise habits, and individual physiology, but the trend is consistent
Insurance and Payment According to MEDVi's terms: "MEDVi-affiliated medical professional entities are not contracted healthcare providers with any health insurance plans (commercial, government, or otherwise, i.e., 'out-of-network' providers)." Patients are responsible for 100% of costs
Therefore, early and aggressive glycemic control, including initial combination therapy when appropriate, may improve the long-term prognosis of people with T2DM
